IBS-C, or irritable bowel syndrome with constipation, doesn’t have a single cause. It results from a combination of disrupted gut motility, heightened nerve sensitivity, changes in the gut microbiome, and a communication breakdown between the brain and the digestive tract. These factors interact differently in each person, which is why the condition varies so much from one individual to the next.
Slowed Motility and Fluid Imbalance
The most direct explanation for the constipation in IBS-C is that the muscles lining the colon don’t contract with the normal rhythm needed to push stool through. When transit slows, the colon absorbs more water from the stool than it should, making it hard and difficult to pass. This isn’t just “being constipated.” In IBS-C, the motility problem is chronic and paired with abdominal pain, which distinguishes it from ordinary constipation.
The fluid balance inside your intestines is tightly regulated by channels in the cells lining the gut wall. These channels control how much chloride, sodium, and water move into or out of the intestinal space. In IBS-C, the balance tips toward too much absorption and not enough secretion. The result: less water in the intestinal space, slower-moving contents, and stools that are hard and lumpy. Many treatments for IBS-C work by targeting exactly this mechanism, pushing more fluid into the intestine to soften stool and speed things along.
The Gut-Brain Connection
Your gut and brain are in constant two-way communication through the nervous system, hormones, and immune signals. In IBS-C, this communication goes awry. The body’s core stress system, known as the HPA axis, plays a central role. When you experience stress, whether physical or psychological, this system releases a cascade of hormones, starting with a signaling molecule in the brain that triggers the release of cortisol and inflammatory proteins.
Research published in Gastroenterology found that cortisol and certain inflammatory markers were elevated across all IBS subtypes, but the elevation was most pronounced in the constipation-predominant group. This suggests that the stress response doesn’t just worsen symptoms emotionally; it actively changes how the gut functions. People with IBS also report higher rates of significant life stressors, including childhood trauma and ongoing psychological distress. These experiences appear to reshape how the stress system responds over time, keeping it in a heightened state that maintains symptoms.
This doesn’t mean IBS-C is “all in your head.” The stress system physically alters gut motility, immune activity, and pain signaling. It’s a biological pathway, not a psychological one.
Visceral Hypersensitivity
Most people with IBS-C experience pain that seems out of proportion to what’s physically happening in the gut. This is called visceral hypersensitivity: the nerves in the intestinal wall become overly reactive, sending amplified pain signals to the brain in response to normal events like gas, stretching, or stool moving through the colon.
Several mechanisms drive this heightened sensitivity. Immune molecules in the gut wall can bind directly to sensory nerve endings, essentially turning up the volume on pain signals. Certain fatty acids produced by gut bacteria activate specialized receptors on cells that produce serotonin, a chemical messenger heavily involved in gut sensation. When serotonin synthesis is altered, the threshold for feeling discomfort drops. Animal studies have shown that transplanting stool from IBS patients into germ-free rats causes the animals to develop lower pain thresholds in the colon, a strong indicator that the microbiome itself contributes to this heightened sensitivity.
Methane-Producing Gut Organisms
One of the more specific findings in IBS-C research involves methane gas. Your gut hosts trillions of microorganisms, and some of them are archaea, ancient single-celled organisms that produce methane as a byproduct of their metabolism. Methane is known to slow intestinal transit. It acts directly on the smooth muscle of the gut wall, reducing the strength and frequency of contractions.
Research presented at Digestive Disease Week found that the proportion of methane-producing archaea increased in step with the severity of constipation in IBS patients. Interestingly, the most abundant human methane producer, a species called Methanobrevibacter smithii, didn’t show a direct link to constipation severity. Instead, two less common species and a specific methane-production pathway (one that converts trimethylamine into methane) were significantly associated with hard stools and incomplete bowel emptying. This suggests the relationship between methane and constipation is more nuanced than a simple “more methane equals worse symptoms” equation.
Low-Grade Inflammation and Gut Barrier Changes
IBS was long considered a purely “functional” disorder, meaning no visible damage or inflammation could be found. That view has shifted. IBS is now increasingly recognized as a low-grade inflammatory condition, though the inflammation is subtle enough that standard tests often miss it.
Part of this involves the gut barrier. The cells lining your intestine are held together by structures called tight junctions, which control what passes from the gut into the bloodstream. In IBS-C, these junctions can weaken, increasing gut permeability (sometimes called “leaky gut” in popular language). When the barrier becomes more permeable, immune cells encounter bacterial components they normally wouldn’t, triggering inflammatory responses that feed into both pain and motility problems. Mast cells, a type of immune cell, have been found in elevated numbers in the colons of IBS patients, though their density tends to be higher in the diarrhea subtype than in the constipation subtype.
Hormonal Fluctuations
IBS-C is roughly twice as common in women as in men, and hormones are a major reason why. Receptors for estrogen and progesterone have been found on cells throughout the gastrointestinal tract, meaning the gut is biologically designed to respond to these hormones.
About 50% of women with IBS report worsening bowel symptoms during menstruation, compared to 34% of women without IBS. Symptoms like abdominal pain, nausea, and bloating tend to peak during menses, when estrogen and progesterone drop to their lowest levels. Bloating also worsens during the second half of the cycle, before menstruation begins. Balloon distention studies have confirmed that women with IBS are physically more sensitive to discomfort in the intestines during their period, not just perceiving it differently but registering it at lower thresholds. The fact that IBS symptoms often decline after menopause, when hormonal fluctuations stop, further supports this connection.
Dietary Triggers
Certain foods don’t cause IBS-C on their own, but they can provoke symptoms in a gut that’s already primed by the mechanisms above. FODMAPs, a group of short-chain carbohydrates found in foods like wheat, garlic, onions, certain fruits, and dairy, are among the most studied triggers. These carbohydrates are poorly absorbed in the small intestine and fermented by bacteria in the colon, producing gas and drawing in extra water.
A low FODMAP diet has solid evidence for reducing the bloating, gas, and pain associated with IBS-C. However, it’s more effective at improving diarrhea than constipation. Some people with IBS-C find it helps their overall symptom burden, but constipation itself may not change much on a low FODMAP approach alone. This makes sense given that the constipation in IBS-C is driven more by motility and fluid imbalance than by dietary fermentation.
Other common dietary triggers include large meals, high-fat foods, caffeine, and alcohol, all of which can alter gut motility or increase sensitivity in different ways. The specific triggers vary widely between individuals, which is why food diaries and structured elimination diets are often more useful than blanket dietary rules.
Why It’s Rarely Just One Thing
What makes IBS-C frustrating for both patients and clinicians is that it almost never traces back to a single broken mechanism. Someone might have mildly slow transit that wouldn’t cause problems on its own, combined with a microbiome that produces excess methane, a stress response that keeps the gut in a reactive state, and hormonal shifts that periodically make everything worse. Each factor amplifies the others. Slow transit gives bacteria more time to ferment and produce gas, which triggers pain signals in an already hypersensitive gut, which feeds back into the stress system, which further slows motility.
This layered nature is why treatments that target only one mechanism often provide partial relief. It also explains why the same treatment works well for one person with IBS-C and barely helps another. The mix of contributing factors is different for each individual, even when the symptoms look the same on the surface.